Type I, II, and III interferon signatures correspond to COVID-19 disease severity
Myung-Ho Kim, Shadi Salloum, Jeffrey Y Wang, Lai Ping Wong, James Regan, Kristina Lefteri, Zachary Manickas-Hill, MGH COVID-19 Collection & Processing Team, Jonathan Z Li, Ruslan I Sadreyev, Xu G Yu, Raymond T Chung
doi: https://doi.org/10.1101/2021.03.10.21253317
Myung-Ho Kim
1Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA, USA
Shadi Salloum
1Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA, USA
Jeffrey Y Wang
1Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA, USA
Lai Ping Wong
2Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA
James Regan
3Department of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA, USA
Kristina Lefteri
4Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
Zachary Manickas-Hill
4Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
5Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Jonathan Z Li
6Department of Infectious Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
Ruslan I Sadreyev
7Department of Molecular Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Xu G Yu
4Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
8Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA
Raymond T Chung
1Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA, USA
Data Availability
Not applicable
Posted March 12, 2021.
Type I, II, and III interferon signatures correspond to COVID-19 disease severity
Myung-Ho Kim, Shadi Salloum, Jeffrey Y Wang, Lai Ping Wong, James Regan, Kristina Lefteri, Zachary Manickas-Hill, MGH COVID-19 Collection & Processing Team, Jonathan Z Li, Ruslan I Sadreyev, Xu G Yu, Raymond T Chung
medRxiv 2021.03.10.21253317; doi: https://doi.org/10.1101/2021.03.10.21253317
Type I, II, and III interferon signatures correspond to COVID-19 disease severity
Myung-Ho Kim, Shadi Salloum, Jeffrey Y Wang, Lai Ping Wong, James Regan, Kristina Lefteri, Zachary Manickas-Hill, MGH COVID-19 Collection & Processing Team, Jonathan Z Li, Ruslan I Sadreyev, Xu G Yu, Raymond T Chung
medRxiv 2021.03.10.21253317; doi: https://doi.org/10.1101/2021.03.10.21253317
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2823)
- Dermatology (242)
- Emergency Medicine (426)
- Epidemiology (12517)
- Forensic Medicine (10)
- Gastroenterology (799)
- Genetic and Genomic Medicine (4397)
- Geriatric Medicine (399)
- Health Economics (712)
- Health Informatics (2831)
- Health Policy (1044)
- Hematology (372)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4155)
- Nursing (220)
- Nutrition (614)
- Oncology (2188)
- Ophthalmology (622)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (263)
- Palliative Medicine (81)
- Pathology (484)
- Pediatrics (1166)
- Primary Care Research (481)
- Public and Global Health (6738)
- Radiology and Imaging (1480)
- Respiratory Medicine (896)
- Rheumatology (429)
- Sports Medicine (361)
- Surgery (469)
- Toxicology (57)
- Transplantation (198)
- Urology (173)